News - Leukaemia Care

11th November 2024

Additional treatment for AML patients now available in Scotland

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today.

31st October 2024

Leukaemia Care’s response to the 2024 Autumn Budget

"We welcome the increase in the NHS budget. However..." - Colin Dyer, Chief Executive at Leukaemia Care shares the charity's response.

22nd October 2024

NEW NHS treatment option for myelofibrosis patients

Certain patients with myelofibrosis will have access to fedratinib to treat myelofibrosis, thanks to a decision made by the National Institute for Health and Care Excellence (NICE).

4th October 2024

New treatment for patients with mastocytosis in England and Wales

Leukaemia Care and UK Masto are pleased to announce that Avapritinib (Ayvakyt©) has been approved for treating advanced systemic mastocytosis in adults in England and Wales, thanks to a decision made by the National Institute for Health and Care Excellence (NICE).

19th September 2024

Additional treatment for AML patients now available in England

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the National Institute for Health and Care Excellence (NICE) today.

12th September 2024

NHS faces crisis: Leukaemia Care continue to be here for leukaemia patients

Read our response below.

5th September 2024

How Leukaemia Care is making a difference in 2024

In the first half of 2024, Leukaemia Care has made a massive impact on those who have been diagnosed or living with a leukaemia diagnosis. Find out more about how we are making a difference in 2024.

2nd September 2024

Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year

Leukaemia charities highlight the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives.

29th August 2024

Myeloproliferative neoplasms (MPNs) treatment shortage: Advice for you

Leukaemia Care is aware of a shortage of interferon alpha, a medication used by some myeloproliferative neoplasm (MPN) patients. If you are concerned or affected by this news, here is some advice based on insights we've received from MPN experts and the charity, MPN Voice.

25th July 2024

NEW oral treatment for ALL patients approved in Scotland

Leukaemia Care are pleased to announce that adult patients with philadelphia chromosome–positive (Ph+) acute lymphoblastic leukaemia (ALL) now have access to Dasatinib thanks to the decision made by the National Cancer Medicines Advisory Group (NCMAG) today.